Cargando…

Unusually prolonged pemetrexed cytotoxicity in a patient with a lung adenocarcinoma: a case report

BACKGROUND: We describe a case of pemetrexed toxicities related to reabsorption by an ileal neobladder, which caused prolonged hematotoxicity and nephrotoxicity. CASE PRESENTATION: A 59-year-old white man was diagnosed with metastatic wild-type adenocarcinoma of the upper lobe of his right lung. Aft...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakhri, Linda, Pinsolle, Julian, Moro-Sibilot, Denis, Pluchart, Hélène
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603063/
https://www.ncbi.nlm.nih.gov/pubmed/28915906
http://dx.doi.org/10.1186/s13256-017-1436-7
_version_ 1783264668572188672
author Sakhri, Linda
Pinsolle, Julian
Moro-Sibilot, Denis
Pluchart, Hélène
author_facet Sakhri, Linda
Pinsolle, Julian
Moro-Sibilot, Denis
Pluchart, Hélène
author_sort Sakhri, Linda
collection PubMed
description BACKGROUND: We describe a case of pemetrexed toxicities related to reabsorption by an ileal neobladder, which caused prolonged hematotoxicity and nephrotoxicity. CASE PRESENTATION: A 59-year-old white man was diagnosed with metastatic wild-type adenocarcinoma of the upper lobe of his right lung. After a first cycle of cisplatin and pemetrexed, he had unusually prolonged aplasia and acute kidney injury. The prolonged aplasia was caused by pemetrexed reabsorption by the ileal mucosa of the neobladder as pemetrexed was eliminated renally in an active form and is partly lipophilic. CONCLUSIONS: Pemetrexed may be reabsorbed by the ileal mucosa of the neobladder because of its hydrophobic structure and renal excretion in its active form. Acute urinary retention may maintain this phenomenon. Published data excluded a potential role for cisplatin in this toxicity; furthermore, we could not assess pemetrexed concentrations in the blood or urine as these assay techniques are not validated. Thus, care is needed when giving chemotherapy to patients with a neobladder.
format Online
Article
Text
id pubmed-5603063
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-56030632017-09-20 Unusually prolonged pemetrexed cytotoxicity in a patient with a lung adenocarcinoma: a case report Sakhri, Linda Pinsolle, Julian Moro-Sibilot, Denis Pluchart, Hélène J Med Case Rep Case Report BACKGROUND: We describe a case of pemetrexed toxicities related to reabsorption by an ileal neobladder, which caused prolonged hematotoxicity and nephrotoxicity. CASE PRESENTATION: A 59-year-old white man was diagnosed with metastatic wild-type adenocarcinoma of the upper lobe of his right lung. After a first cycle of cisplatin and pemetrexed, he had unusually prolonged aplasia and acute kidney injury. The prolonged aplasia was caused by pemetrexed reabsorption by the ileal mucosa of the neobladder as pemetrexed was eliminated renally in an active form and is partly lipophilic. CONCLUSIONS: Pemetrexed may be reabsorbed by the ileal mucosa of the neobladder because of its hydrophobic structure and renal excretion in its active form. Acute urinary retention may maintain this phenomenon. Published data excluded a potential role for cisplatin in this toxicity; furthermore, we could not assess pemetrexed concentrations in the blood or urine as these assay techniques are not validated. Thus, care is needed when giving chemotherapy to patients with a neobladder. BioMed Central 2017-09-16 /pmc/articles/PMC5603063/ /pubmed/28915906 http://dx.doi.org/10.1186/s13256-017-1436-7 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Sakhri, Linda
Pinsolle, Julian
Moro-Sibilot, Denis
Pluchart, Hélène
Unusually prolonged pemetrexed cytotoxicity in a patient with a lung adenocarcinoma: a case report
title Unusually prolonged pemetrexed cytotoxicity in a patient with a lung adenocarcinoma: a case report
title_full Unusually prolonged pemetrexed cytotoxicity in a patient with a lung adenocarcinoma: a case report
title_fullStr Unusually prolonged pemetrexed cytotoxicity in a patient with a lung adenocarcinoma: a case report
title_full_unstemmed Unusually prolonged pemetrexed cytotoxicity in a patient with a lung adenocarcinoma: a case report
title_short Unusually prolonged pemetrexed cytotoxicity in a patient with a lung adenocarcinoma: a case report
title_sort unusually prolonged pemetrexed cytotoxicity in a patient with a lung adenocarcinoma: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603063/
https://www.ncbi.nlm.nih.gov/pubmed/28915906
http://dx.doi.org/10.1186/s13256-017-1436-7
work_keys_str_mv AT sakhrilinda unusuallyprolongedpemetrexedcytotoxicityinapatientwithalungadenocarcinomaacasereport
AT pinsollejulian unusuallyprolongedpemetrexedcytotoxicityinapatientwithalungadenocarcinomaacasereport
AT morosibilotdenis unusuallyprolongedpemetrexedcytotoxicityinapatientwithalungadenocarcinomaacasereport
AT plucharthelene unusuallyprolongedpemetrexedcytotoxicityinapatientwithalungadenocarcinomaacasereport